SOLARA ACTIVE PHARMA SCIENCES LIMITED — Regulatory Filings 2026

May 12, 2026

SOLARA
Active Pharma Sciences
Corporate Office:
Solara Active Pharma Sciences Limited
TICEL Bio Park, 6th Floor,
Module No. 601, 602, 603, Phase II – CSIR Road,
Taramani, Chennai, Tamil Nadu – 600113.
Tel: +91 44 4344 6700
Fax: +91 44 47406190
E-mail: investors@solara.co.in
Website: www.solara.co.in

Date: May 12, 2026

| The BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street, Mumbai – 400 001 | The National Stock Exchange of India Limited
Exchange Plaza, C-1, Block G, Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051 |
| --- | --- |

Scrip Code: 541540, 890202
Symbol: SOLARA, SOLARAPP1

Dear Sir / Madam,

Subject: Revised intimation of Analysts / Investors Conference Call
Ref: Our Intimation dated May 11, 2026

We refer to our intimation filed with BSE Limited and National Stock Exchange of India Limited dated May 11, 2026, pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is to inform you that there has been a change in panel member for the conference call with analysts/ investors, which is scheduled to be held on Friday, May 15, 2026, at 3.00 P.M. IST to discuss Company’s audited financial results for the quarter and year ended March 31, 2026 as per the following details:

Day and Date	Time	Meeting Type	Scheduled for
Friday, May 15, 2026	03:00 P.M (IST)	Conference Call – Group Meet	Investors/ Analysts

Due to unavoidable scheduling conflict, one of the management's panel member is unable to attend the said investors call. However, the remaining panel members will participate as scheduled. Revised Analysts / Investors Conference Call details are enclosed for ready reference. All other details of the conference call remain unchanged.

The change is being notified as a matter of transparency and in compliance with applicable regulatory requirements.

Further, kindly note that the above information will also be available on the website of the Company i.e., https://solara.co.in/investor-relations/schedule-of-investors-meet-and-investors-presentations/

This is for your information and records.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

POOJA JAYA
KUMAR

POOJA Jaya Kumar
Company Secretary & Compliance Officer
Membership No: A57415

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636
Registered Office: 9th Floor, 'Cyber One', Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033

---

Solara Conference Call
Friday, 15th May 2026, 3:00 pm IST

Pure play APIs.

SOLARA ACTIVE PHARMA SCIENCES | Q4FY26

Sandeep Rao, MD & CEO
Sarat Kumar, CFO

Dial in Details:	For Solara's conference call, Friday 15th May 2026, 3:00 pm IST
Universal Access	+91 22 6280 1346
+91 22 7115 8247
Diamond Pass
(for early registration)	Click here